745251
Last Update Posted: 2012-10-05
Recruiting has ended
All Genders accepted | 30 Years-65 Years |
45 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults
The primary objectives of this study are to evaluate the safety and efficacy of VI-0521 compared to placebo in the treatment of obese adults with obstructive sleep apnea (OSA) and to assess the relative contributions of weight loss on parameters of OSA in these subjects.
Eligibility
Relevant conditions:
Sleep Apnea
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov